DESI2 and colorectal cancer: DESI2 combined with IP10 further enhanced the apoptosis in colorectal cancer and lung adenocarcinoma cancer cells, as indicated by MTT (Figure 1C), colony-formation assays (Figure 1D–1F), flow cytometric analysis (Figure 2A) and Hoechst 33258 staining (Figure 2B).